Home › Funds › Sensenig Capital Advisors, Inc › ABBV

Sensenig Capital Advisors, Inc position in ABBV

ABBVIE INC · Health Care

Sensenig Capital Advisors, Inc reported holding 1,356 shares of ABBV (ABBVIE INC) in its Q2 2026 13F filing — a position valued at US$341K, representing 0.31% of its reported portfolio and ranking #25 among its reported holdings. Sensenig Capital Advisors, Inc has disclosed ABBV holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)1.36K sh
Reported value held$341.22K
Portfolio Weight0.31%
First reportedQ4 2025
Last changeReduce
Updated2026-10-24

How Sensenig Capital Advisors, Inc's ABBV position evolved

Sensenig Capital Advisors, Inc first disclosed a stake in ABBV in Q4 2025 at 1,456 shares (US$333K). The position peaked in Q2 2026 at 1,356 shares, worth US$341K. Across 3 filings, Sensenig Capital Advisors, Inc increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,356 shares valued at US$341K — a reduction of -100 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 1.46K $332.68K New
Q1 2026 1.46K $316.67K Hold
Q2 2026 1.36K $341.22K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 35 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$29.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →